Vascular Dementia

Understanding Vascular Dementia

A Vascular Injury, Not a Protein Disease

Vascular dementia begins with damaged or blocked blood vessels rather than with the slow buildup of abnormal proteins. The brain consumes roughly one-fifth of the body's oxygen at rest, and even brief interruptions of blood flow can kill neurons. When the injuries accumulate — whether as a single large stroke, multiple smaller strokes, or chronic damage to deep-brain vessels — the resulting cognitive impairment is what clinicians call vascular cognitive impairment or, when severe, vascular dementia.

The umbrella term "vascular cognitive impairment" (VCI) is used to cover the entire spectrum, from subtle deficits after a transient ischemic attack to fully established dementia. This broader framing has become useful clinically because it captures patients who are still functionally independent yet measurably affected, and who stand to gain most from vascular prevention.

Common Combination With Alzheimer's

Pure vascular dementia is increasingly considered the exception rather than the rule in older adults. Autopsy studies show that most people with dementia over age 80 have a mixture of Alzheimer's pathology, vascular lesions, and often other neurodegenerative changes such as Lewy bodies or TDP-43. Vascular disease lowers the threshold at which Alzheimer's pathology produces symptoms, and Alzheimer's may impair vascular regulation. Treating both contributors offers the best chance of stabilizing cognition.

Why Executive Function Suffers Early

Many strokes and small vessel injuries occur in the deep white matter and subcortical structures that connect frontal lobes to the rest of the brain. These pathways subserve planning, attention, processing speed, working memory, and the ability to switch flexibly between tasks. As a result, in many cases of vascular cognitive impairment, executive symptoms — slowed thinking, difficulty multitasking, impaired judgment — show up before any noticeable memory failure, distinguishing the early picture from Alzheimer's disease.

Who Develops Vascular Dementia

• Older adults, especially those with longstanding cardiovascular disease
• People with poorly controlled hypertension, particularly from midlife onward
• Survivors of clinical strokes — about a third develop some degree of cognitive impairment
• People with diabetes, atrial fibrillation, or coronary disease
• Smokers and those with longstanding sleep apnea
• Patients with hereditary small vessel disease such as CADASIL
• Communities with disproportionate burden of untreated cardiovascular risk

DSM-5 Diagnostic Criteria

The DSM-5 specifies Major or Mild Neurocognitive Disorder Due to Vascular Disease as a distinct etiology under the broader neurocognitive disorder framework.

Core Cognitive Criteria

Evidence of decline from a prior level of performance in one or more cognitive domains is required — significant decline for the Major category, modest decline for the Mild category. The decline is documented either by concern from the patient, an informant, or a clinician, and by objective assessment, ideally with standardized neuropsychological testing. For Major NCD the deficits interfere with independence; for Mild NCD they do not, though greater effort or compensatory strategies are needed.

Evidence for Vascular Etiology

The diagnosis additionally requires features consistent with a vascular cause, such as:

• Onset of cognitive deficits temporally related to one or more cerebrovascular events
• A prominent decline in complex attention (including processing speed) and frontal-executive function
• Evidence of significant cerebrovascular disease from history, physical exam, or neuroimaging sufficient to account for the deficits

Probable vs. Possible

The DSM-5 distinguishes "probable" from "possible" vascular NCD. Probable requires either neuroimaging evidence of significant parenchymal injury attributed to cerebrovascular disease, a clear temporal relationship to a documented cerebrovascular event, or both clinical and genetic evidence of cerebrovascular disease. Possible vascular NCD applies when the clinical picture is consistent with vascular causation but the supporting evidence is incomplete.

Exclusions

• The deficits cannot occur exclusively in the context of a delirium
• The disturbance cannot be better explained by another neurocognitive or mental disorder

Specifiers

As with other neurocognitive disorders, clinicians can specify the severity (mild, moderate, severe) and the presence or absence of behavioral disturbance such as psychotic features, mood symptoms, agitation, or apathy.

Relationship to Other Diagnostic Frameworks

Older frameworks such as the NINDS-AIREN criteria emphasized abrupt onset, stepwise deterioration, and focal neurological signs. These features remain useful clinical pointers but are not present in all cases — for example, small vessel subcortical disease often produces gradual, smooth decline rather than stepwise change. Contemporary practice integrates clinical history, neuropsychological pattern, and imaging findings rather than relying on a single feature.

Subtypes and Mechanisms

Post-Stroke Dementia

A single large strategic stroke — particularly one affecting the thalamus, hippocampus, angular gyrus, or basal forebrain — can produce dementia by itself, even without prior cognitive disease. The timing is typically clear: a sudden neurological event is followed within days or months by new cognitive symptoms. Roughly one in three stroke survivors meets criteria for some form of cognitive impairment within a year, ranging from mild deficits to frank dementia.

Multi-Infarct Dementia

The classic stepwise pattern, often visible on imaging as multiple cortical or subcortical infarcts. Each stroke produces a discrete drop in function followed by a partial plateau, and the cumulative loss eventually crosses the threshold for dementia. This pattern is most often seen in patients with longstanding hypertension, diabetes, or recurrent embolic disease from atrial fibrillation.

Subcortical Small Vessel Disease

Chronic damage to the small penetrating arteries that supply deep white matter and basal ganglia produces lacunar infarcts, white matter hyperintensities, and microhemorrhages. The clinical picture tends to be gradual rather than stepwise, with prominent slowing of thinking, executive dysfunction, gait disturbance, and urinary changes. This is the form most commonly associated with chronic hypertension and is often visible as extensive white matter changes on MRI.

Strategic Infarct Dementia

A small stroke in a critical location — a thalamic nucleus, the head of the caudate, the medial frontal lobe — can produce dramatic cognitive symptoms disproportionate to its size. Apathy, abulia, severe attentional deficits, or amnestic syndromes may dominate.

Hypoperfusion-Related Injury

Global reduction in cerebral blood flow, as may occur after cardiac arrest or in severe hypotension, can produce watershed infarcts in territories vulnerable to reduced perfusion. These watershed lesions disrupt connectivity between cortical regions and can cause significant cognitive impairment.

Hemorrhagic Causes

Intracerebral hemorrhage, particularly cerebral amyloid angiopathy in older adults, can both cause vascular dementia directly and overlap with Alzheimer's pathology. Cerebral amyloid angiopathy presents with lobar microbleeds and superficial siderosis on susceptibility-weighted MRI.

Inherited Small Vessel Diseases

CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy), caused by NOTCH3 mutations, is the prototype of inherited small vessel disease. It causes migraines with aura, recurrent subcortical strokes, mood symptoms, and progressive cognitive decline often beginning in middle age. CARASIL and other rarer syndromes also exist and should be considered in young or strongly familial cases.

Mixed Vascular and Alzheimer's Pathology

The most common pattern in the very old. The clinical presentation often blends features of both diseases, and the two pathologies appear to amplify each other. Mixed dementia is the rule rather than the exception in centenarians and in many community-based dementia cohorts.

Symptoms and Warning Signs

Cognitive Symptoms

• Slowed thinking and reduced processing speed, often described as "I'm just slower now"
• Trouble planning, organizing, multitasking, and shifting between activities
• Reduced attention and difficulty filtering distractions
• Memory difficulty that often improves with cues, unlike the encoding failure of Alzheimer's
• Word-finding difficulty and reduced verbal fluency
• Impaired judgment and reduced insight

Neurological Signs

• Focal weakness or sensory loss attributable to past strokes
• Gait disturbance — short steps, wide base, magnetic gait (feet seemingly stuck to the floor)
• Pseudobulbar affect — laughing or crying out of proportion to felt emotion
• Dysarthria and dysphagia
• Urinary urgency or incontinence appearing earlier than in Alzheimer's
• Parkinsonian features in some cases of subcortical small vessel disease

Mood and Behavior

• Apathy and reduced initiative, sometimes the most prominent symptom
• Depression — common after stroke and a recognized risk factor for cognitive decline
• Anxiety and emotional lability
• Irritability or disinhibition in cases with frontal involvement
• Less prominent visual hallucinations than in Lewy body disease, though they can occur

Stepwise vs. Gradual Patterns

A history of one or more clinical strokes followed by abrupt drops in cognition with partial recoveries is highly suggestive of vascular dementia. In small vessel disease, however, the decline can be smooth and indistinguishable on history alone from Alzheimer's. Imaging then plays a critical role in identifying the vascular contribution.

Causes and Risk Factors

Hypertension

Chronic elevation of blood pressure damages the walls of small arteries throughout the brain, accelerates atherosclerosis in larger vessels, and increases the risk of both ischemic and hemorrhagic stroke. Midlife hypertension is more strongly linked to later cognitive decline than late-life hypertension. The SPRINT MIND trial showed that intensive blood pressure control (target systolic below 120) reduced the incidence of mild cognitive impairment and the combined endpoint of MCI or dementia compared with standard control.

Diabetes and Insulin Resistance

Diabetes roughly doubles the risk of vascular dementia. Hyperglycemia damages small vessels, and repeated severe hypoglycemic episodes are themselves directly neurotoxic. Insulin resistance also appears to contribute to amyloid handling, linking diabetes to Alzheimer's pathology as well.

Hyperlipidemia

Elevated LDL cholesterol drives atherosclerosis in cerebral and carotid arteries. Statin therapy reduces stroke risk, with downstream benefit for cognition through stroke prevention.

Atrial Fibrillation

Atrial fibrillation increases stroke risk approximately fivefold. Even in patients without overt stroke, atrial fibrillation is associated with silent infarcts and accelerated cognitive decline. Appropriate anticoagulation in eligible patients reduces both clinical stroke and cognitive decline.

Smoking

Smoking damages endothelial function, raises blood pressure, accelerates atherosclerosis, and increases the risk of every type of cerebrovascular event. Smoking cessation reduces stroke risk significantly within a few years and remains one of the highest-impact lifestyle changes.

Other Risk Factors

• Obstructive sleep apnea, which causes intermittent hypoxia and blood pressure surges
• Obesity and metabolic syndrome
• Chronic kidney disease, itself a marker of vascular disease
• Coronary artery disease and prior myocardial infarction
• Cardiac arrest with hypoxic-ischemic injury
• Heavy alcohol use
• Air pollution exposure

Nonmodifiable Factors

• Advancing age
• Male sex (higher stroke risk at younger ages, equalizing in later life)
• Family history of stroke or early vascular dementia
• Genetic conditions such as CADASIL
• Race and ethnicity — disproportionate vascular burden in Black and Hispanic populations, largely attributable to social determinants and untreated risk factors

The Window of Opportunity

Because vascular damage accumulates over decades, midlife is the highest-yield window for prevention. Blood pressure, cholesterol, and glucose control in the 40s, 50s, and 60s have a disproportionately large effect on cognitive trajectory in the 70s and 80s. Waiting until cognitive symptoms appear before addressing vascular risk forfeits much of this benefit.

Medical Complications

Recurrent Stroke

The single most important complication. Each additional stroke worsens cognition, function, and survival. Secondary prevention — antithrombotic therapy, blood pressure control, statins, lifestyle change — is critical and is, in effect, the primary treatment of vascular dementia.

Falls and Fractures

Gait disturbance from subcortical disease, combined with focal weakness and impaired judgment, raises fall risk substantially. Hip and other major fractures often precipitate sharp functional and cognitive decline.

Cardiovascular Events

The same vascular pathology that injures the brain also damages the heart. Coronary events, heart failure, and peripheral arterial disease commonly coexist and contribute to mortality.

Depression

Post-stroke depression occurs in roughly one in three stroke survivors and is itself a risk factor for further cognitive decline. Recognition and treatment improve both mood and cognitive trajectory.

Aspiration and Pneumonia

Bulbar dysfunction from previous strokes or from white matter disease impairs swallowing and increases pneumonia risk. Swallow evaluation and modified diets are important parts of care.

Urinary Symptoms

Detrusor overactivity and reduced cortical inhibition lead to urinary urgency and incontinence, which can be socially isolating and contribute to skin breakdown and infections.

Delirium

People with vascular cognitive impairment are particularly vulnerable to delirium during hospitalization or acute medical illness. Each episode can leave residual decline.

Assessment and Diagnosis

History

A careful timeline is essential. Clinicians look for stepwise changes after vascular events, gradual subcortical-type slowing, prior transient ischemic attacks, hypertension and diabetes history, smoking, family history of early stroke, and a medication review. An informant interview helps identify changes the patient may not recognize.

Neurological Examination

Focal weakness, sensory loss, hyperreflexia, primitive reflexes, gait abnormalities, and pseudobulbar signs all support a vascular contribution to cognitive symptoms.

Cognitive Testing

• MoCA is preferred over MMSE because of its sensitivity to executive dysfunction
• Trail Making Test, particularly Part B, captures executive slowing well
• Verbal fluency tasks (animal naming, letter fluency) are often reduced
• Memory testing typically shows that recognition is preserved relative to free recall — a pattern distinct from Alzheimer's, where both are impaired

Brain Imaging

Imaging is essential to confirm cerebrovascular pathology. MRI is the test of choice and may show:

• Cortical or subcortical infarcts of varying age
• Extensive white matter hyperintensities on FLAIR or T2 sequences
• Lacunar infarcts in basal ganglia, thalami, or pons
• Cerebral microbleeds on susceptibility-weighted imaging
• Cortical atrophy that may be focal or diffuse
• Evidence of cerebral amyloid angiopathy in older patients

The burden of small vessel disease can be scored using validated visual rating scales such as the Fazekas scale, which helps quantify severity and track change.

Vascular Workup

• Blood pressure measurement, including ambulatory monitoring if variability is suspected
• Lipid profile, fasting glucose or HbA1c
• Electrocardiogram and, when atrial fibrillation is suspected, prolonged rhythm monitoring
• Echocardiogram in cases of suspected embolic source
• Carotid Doppler ultrasound when carotid stenosis is a concern
• Thrombophilia or autoimmune workup in atypical young-onset cases

Distinguishing From Alzheimer's

No single feature is definitive. Pointers toward vascular causation include prominent early executive dysfunction relative to memory, stepwise change, focal neurological signs, vascular risk factors, and significant cerebrovascular lesions on imaging. Pointers toward Alzheimer's include an early and disproportionate amnestic syndrome, gradual smooth decline, medial temporal atrophy, and positive amyloid biomarkers. In many older patients, both pictures coexist.

Treatment Approaches

Aggressive Vascular Risk Factor Management

The cornerstone of vascular dementia treatment is preventing additional brain injury. Specific targets include:

• Systolic blood pressure ideally toward 120–130 mmHg in tolerant patients, with individualized targets in the frail elderly
• HbA1c targets individualized to avoid both hyperglycemia and dangerous hypoglycemia
• LDL cholesterol reduction with statin therapy in those with established cerebrovascular disease
• Antithrombotic therapy — antiplatelet agents after most ischemic strokes, anticoagulation for atrial fibrillation when appropriate
• Smoking cessation, with combined behavioral support and pharmacotherapy
• Treatment of obstructive sleep apnea
• Carotid revascularization in selected patients with high-grade symptomatic stenosis

Cholinesterase Inhibitors and Memantine

Donepezil and galantamine have demonstrated modest cognitive benefit in some trials of vascular dementia and are commonly used, although not FDA-approved for this indication. The effect size is smaller than in Alzheimer's. Memantine has limited evidence in pure vascular dementia. In mixed dementia, these medications are reasonable given the high likelihood of overlapping Alzheimer's pathology.

Exercise and Physical Rehabilitation

Aerobic exercise improves vascular function, lowers blood pressure, supports glycemic control, and has independent benefits for cognition and mood. After stroke, structured rehabilitation focused on mobility, strength, balance, and aerobic capacity is associated with better cognitive outcomes. Physical therapy addresses gait disturbance and reduces fall risk.

Cognitive and Speech Therapy

Speech-language pathology helps with post-stroke aphasia, dysarthria, and swallowing difficulties. Cognitive rehabilitation focusing on attention, processing speed, and compensatory strategies can support functional independence, particularly when targeted to specific real-world goals.

Treating Depression and Apathy

Post-stroke depression responds to antidepressants and to behavioral activation. Treatment improves both mood and cognitive recovery. Apathy, which is distinct from depression and very common in subcortical vascular disease, is less reliably responsive to medication but may improve with structured routines and engaging activities.

Behavioral and Psychological Symptoms

As in other dementias, nonpharmacological strategies are preferred. When medication is necessary for severe agitation or psychosis, the same cautions apply: antipsychotics carry increased mortality risk in older adults with dementia, benzodiazepines worsen confusion and falls, and the lowest effective dose should be used for the shortest time.

Diet

The Mediterranean and MIND dietary patterns, with emphasis on vegetables, fruits, whole grains, legumes, nuts, olive oil, fish, and limited red and processed meat, are associated with reduced vascular and cognitive risk. The DASH dietary pattern is specifically helpful for blood pressure control.

Lifestyle Integration

Sleep, social engagement, treatment of hearing loss, smoking cessation, and limiting alcohol all contribute to brain health. Multidomain interventions modeled on the FINGER trial are being adapted to vascular cognitive impairment with promising results.

Advance Care Planning

Vascular dementia trajectories vary widely. Advance directives, healthcare proxies, and conversations about preferences regarding future events — another stroke, hospitalization, life-prolonging measures — should be revisited at intervals while the person can participate meaningfully.

Living With Vascular Dementia

Daily Adaptations

People with vascular cognitive impairment often function well when tasks are simplified, environments are predictable, and pace is slowed. Strategies include a single shared calendar, written checklists for multistep activities, medication organizers with weekly setup, and reminders for appointments. Allowing extra time for tasks reduces frustration and accidents.

Home and Safety

• Remove tripping hazards, improve lighting, and consider grab bars and shower seats
• Adapt the home for any focal weakness or mobility limitation
• Set up emergency alert systems for someone living alone
• Use blood pressure cuffs at home with shared logs for clinicians
• Plan how to recognize and act on stroke symptoms quickly

Driving

Driving safety after stroke or with significant cognitive impairment needs formal evaluation. Reaction time, visual scanning, and judgment can all be affected. A comprehensive driving assessment through occupational therapy provides objective input, and decisions made with professional support are easier to accept than confrontations within the family.

Support Networks

• Stroke survivor groups for those whose vascular dementia followed a clinical stroke
• Caregiver support groups, in person and online
• Local Alzheimer's Association chapters, which serve all dementias
• Aging services and area agencies on aging for community resources

For Caregivers

Caregiving in vascular dementia carries the same physical and emotional load as in other dementias, with the added stress of potential acute events such as another stroke. Sustainable caregiving requires acceptance of help, attention to one's own physical and mental health, regular respite, and planning for the possibility of higher levels of care. The role is enormous and is rarely sustainable without a team.

Late-Stage and Palliative Care

In advanced vascular dementia, the focus shifts to comfort, dignity, and presence. Goals of care discussions, palliative consultation, and hospice services help families navigate decisions about hospitalization, antibiotics for recurrent infections, and feeding. A peaceful, well-supported death is achievable with planning.

When to Seek Help

Emergency Situations

Sudden onset of any neurological symptom — weakness, numbness, speech change, vision change, severe headache, loss of balance, or sudden confusion — should be treated as a possible stroke and trigger an immediate call to emergency services. Time is brain: clot-directed therapies are most effective within hours of symptom onset.

Nonemergency Concerns

Persistent changes in thinking, memory, mood, gait, or behavior in a person with vascular risk factors warrant a clinical evaluation. Identification of vascular contributions allows targeted prevention even if symptoms are mild.

Red Flags

• Rapid cognitive decline over weeks (consider new strokes, autoimmune disease, malignancy)
• Frequent falls, especially with loss of consciousness
• New focal neurological signs
• Significant mood change, hopelessness, or suicidal thoughts
• Recurrent hospitalizations or episodes of delirium
• Caregiver exhaustion or any signs of unsafe living situation

Where to Start

• Primary care for initial evaluation, vascular risk assessment, and referrals
• Neurologist or stroke specialist for evaluation of cerebrovascular disease and prevention strategy
• Geriatrician or geriatric psychiatrist for complex cognitive and behavioral care
• Memory clinics that integrate cognitive, vascular, and psychosocial evaluation
• Rehabilitation services for physical, occupational, and speech therapy after stroke